Article Text

Download PDFPDF

Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment.
  1. S. M. Abrams,
  2. L. R. Baker,
  3. P. Crome,
  4. A. S. White,
  5. A. Johnston,
  6. S. I. Ankier,
  7. S. J. Warrington,
  8. P. Turner,
  9. G. Niebch
  1. Department of Clinical Pharmacology, St Bartholomew's Hospital, London, UK.


    The pharmacokinetics of flupirtine after a single oral dose of 100mg have been studied in patients with moderate renal impairment and in healthy elderly subjects aged 66-83 years. Mean elimination half-life of flupirtine was higher in elderly patients than in younger normal subjects, and this was associated with an increased maximum serum concentration and reduced clearance. The mean half-life in patients with renal impairment was higher than in normal subjects. There was no correlation between observed elimination half-life and degree of renal impairment, but the creatinine clearance of most patients fell in a narrow range between 43 and 60 ml/min. In the light of these results and until further information is available, it would be prudent to start treatment of patients who are elderly or have evidence of renal impairment with half the dose of flupirtine recommended for younger patients with normal renal function.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.